G

Global Health Ltd
NSE:MEDANTA

Watchlist Manager
Global Health Ltd
NSE:MEDANTA
Watchlist
Price: 1 113.65 INR 3.8% Market Closed
Market Cap: 299.1B INR
Have any thoughts about
Global Health Ltd?
Write Note

Intrinsic Value

The intrinsic value of one MEDANTA stock under the Base Case scenario is 792.23 INR. Compared to the current market price of 1 113.65 INR, Global Health Ltd is Overvalued by 29%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MEDANTA Intrinsic Value
792.23 INR
Overvaluation 29%
Intrinsic Value
Price
G
Worst Case
Base Case
Best Case

Valuation Backtest
Global Health Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MEDANTA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MEDANTA?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Global Health Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Global Health Ltd

Provide an overview of the primary business activities
of Global Health Ltd.

What unique competitive advantages
does Global Health Ltd hold over its rivals?

What risks and challenges
does Global Health Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Global Health Ltd.

Provide P/S
for Global Health Ltd.

Provide P/E
for Global Health Ltd.

Provide P/OCF
for Global Health Ltd.

Provide P/FCFE
for Global Health Ltd.

Provide P/B
for Global Health Ltd.

Provide EV/S
for Global Health Ltd.

Provide EV/GP
for Global Health Ltd.

Provide EV/EBITDA
for Global Health Ltd.

Provide EV/EBIT
for Global Health Ltd.

Provide EV/OCF
for Global Health Ltd.

Provide EV/FCFF
for Global Health Ltd.

Provide EV/IC
for Global Health Ltd.

Show me price targets
for Global Health Ltd made by professional analysts.

What are the Revenue projections
for Global Health Ltd?

How accurate were the past Revenue estimates
for Global Health Ltd?

What are the Net Income projections
for Global Health Ltd?

How accurate were the past Net Income estimates
for Global Health Ltd?

What are the EPS projections
for Global Health Ltd?

How accurate were the past EPS estimates
for Global Health Ltd?

What are the EBIT projections
for Global Health Ltd?

How accurate were the past EBIT estimates
for Global Health Ltd?

Compare the revenue forecasts
for Global Health Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Global Health Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Global Health Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Global Health Ltd compared to its peers.

Compare the P/E ratios
of Global Health Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Global Health Ltd with its peers.

Analyze the financial leverage
of Global Health Ltd compared to its main competitors.

Show all profitability ratios
for Global Health Ltd.

Provide ROE
for Global Health Ltd.

Provide ROA
for Global Health Ltd.

Provide ROIC
for Global Health Ltd.

Provide ROCE
for Global Health Ltd.

Provide Gross Margin
for Global Health Ltd.

Provide Operating Margin
for Global Health Ltd.

Provide Net Margin
for Global Health Ltd.

Provide FCF Margin
for Global Health Ltd.

Show all solvency ratios
for Global Health Ltd.

Provide D/E Ratio
for Global Health Ltd.

Provide D/A Ratio
for Global Health Ltd.

Provide Interest Coverage Ratio
for Global Health Ltd.

Provide Altman Z-Score Ratio
for Global Health Ltd.

Provide Quick Ratio
for Global Health Ltd.

Provide Current Ratio
for Global Health Ltd.

Provide Cash Ratio
for Global Health Ltd.

What is the historical Revenue growth
over the last 5 years for Global Health Ltd?

What is the historical Net Income growth
over the last 5 years for Global Health Ltd?

What is the current Free Cash Flow
of Global Health Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Global Health Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Global Health Ltd

Current Assets 15.1B
Cash & Short-Term Investments 12.1B
Receivables 2.2B
Other Current Assets 837.1m
Non-Current Assets 28B
Long-Term Investments 272.3m
PP&E 26.2B
Intangibles 55.4m
Other Non-Current Assets 1.4B
Current Liabilities 6.2B
Accounts Payable 1.9B
Other Current Liabilities 4.3B
Non-Current Liabilities 7.8B
Long-Term Debt 6.3B
Other Non-Current Liabilities 1.5B
Efficiency

Earnings Waterfall
Global Health Ltd

Revenue
33.5B INR
Cost of Revenue
-7.9B INR
Gross Profit
25.6B INR
Operating Expenses
-19.5B INR
Operating Income
6.1B INR
Other Expenses
-1.3B INR
Net Income
4.8B INR

Free Cash Flow Analysis
Global Health Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MEDANTA Profitability Score
Profitability Due Diligence

Global Health Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROE
Positive Revenue Growth Forecast
60/100
Profitability
Score

Global Health Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

MEDANTA Solvency Score
Solvency Due Diligence

Global Health Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
77/100
Solvency
Score

Global Health Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MEDANTA Price Targets Summary
Global Health Ltd

Wall Street analysts forecast MEDANTA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDANTA is 1 225.7 INR with a low forecast of 863.55 INR and a high forecast of 1 512 INR.

Lowest
Price Target
863.55 INR
22% Downside
Average
Price Target
1 225.7 INR
10% Upside
Highest
Price Target
1 512 INR
36% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MEDANTA?

Click here to dive deeper.

Dividends

Global Health Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for MEDANTA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Global Health Ltd

Country

India

Industry

Health Care

Market Cap

299B INR

Dividend Yield

0%

Description

Global Health Ltd. engages in the provision of healthcare, pathology, and other medical services. The company is headquartered in New Delhi, Delhi and currently employs 9,350 full-time employees. The company went IPO on 2022-11-16. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna and Lucknow through its network of five hospitals, six Mediclinic, diagnostic laboratories, homecare and telemedicine services. The company provides treatments for coronary artery disease, head and neck cancer, acute myeloid leukemia, epilepsy, hip fracture, Parkinson's disease, refractive error, prostate cancer, chronic kidney disease, cerebral stroke, sepsis, liver cirrhosis, rheumatoid, arthritis, hypertension, diabetes, bronchial asthma, stomach cancer, and chronic otitis media. Medanta specializes in cardiac surgery, nephrology, urology, andrology, dermatology, ophthalmology, radiology and imaging, dental sciences, and interventional cardiology, among others. Its facilities and services include medicine delivery, air ambulance, patient support services, and others.

Contact

DELHI
New Delhi
E-18, Defence Colony
+911244834060
www.medanta.org

IPO

2022-11-16

Employees

9 350

Officers

Chairman & MD
Dr. Naresh Kumar Trehan
Group CEO & Additional Whole Time Director
Mr. Pankaj Prakash Sahni
Chief Financial Officer
Mr. Yogesh Kumar Gupta
Chief Information Officer
Mr. Rajiv Sikka
Company Secretary & Compliance Officer
Mr. Rahul Ranjan
General Counsel
Ms. Richa Singh
Show More
Senior VP & Head of Human Resources
Mr. Saurabh Upadhyay
Chief Procurement Officer
Mr. Bhuvander Kaul
Chief Strategy Officer
Dr. Sandeep Sawhney
Show Less

See Also

Discover More
What is the Intrinsic Value of one MEDANTA stock?

The intrinsic value of one MEDANTA stock under the Base Case scenario is 792.23 INR.

Is MEDANTA stock undervalued or overvalued?

Compared to the current market price of 1 113.65 INR, Global Health Ltd is Overvalued by 29%.

Back to Top